News
Cloud revenue at Microsoft rises 27% in the software giant’s fiscal fourth quarter, while second-quarter revenue at Meta ...
Bristol Myers Squibb (BMY) is gearing up for its earnings release this Thursday. Historically, the stock's one-day ...
Novo Nordisk promoted Maziar Mike Doustdar to president and CEO, effective August 7. The Food and Drug Administration tapped newly appointed George Tidmarsh as acting Center for Biologics Evaluation ...
This was the stock's fifth consecutive day of losses.
Bristol-Myers Squibb Company ( NYSE: BMY) is scheduled to announce Q2 earnings results on July 31st, before markets open.
Bristol-Myers Squibb unveils its earnings this Thursday. Last quarter, they beat revenue estimates by nearly 4%. Now, ...
AI-powered quantification of tumor-infiltrating lymphocytes could change how patients with melanoma are treated after surgery ...
You also don't need a substantial amount of money on hand to invest. Here are three prominent healthcare companies you can ...
StockStory.org on MSN1d
Bristol-Myers Squibb (BMY) Q2 Earnings: What To ExpectBiopharmaceutical company Bristol Myers Squibb (NYSE:BMY) will be reporting results this Thursday morning. Here’s what you ...
Bristol Myers Squibb and Bain Capital have formed a new independent biopharmaceutical company focused on developing new ...
AbbVie, Bristol Myers Squibb and Eli Lilly appear “relatively well-positioned,” while Novartis and Roche look more at risk, ...
The FDA has accepted for review the sNDA for deucravacitinib for the treatment of adults with active psoriatic arthritis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results